These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 29890743)
1. Molecular Genetics of Frontotemporal Dementia Elucidated by Vandal SE; Zheng X; Ahmad ST Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890743 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective activity of ursodeoxycholic acid in CHMP2B West RJH; Ugbode C; Fort-Aznar L; Sweeney ST Neurobiol Dis; 2020 Oct; 144():105047. PubMed ID: 32801000 [TBL] [Abstract][Full Text] [Related]
3. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III. Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479 [TBL] [Abstract][Full Text] [Related]
4. The role of CHMP2B Krasniak CS; Ahmad ST Brain Res; 2016 Oct; 1649(Pt B):151-157. PubMed ID: 26972529 [TBL] [Abstract][Full Text] [Related]
5. Expression of mutant CHMP2B, an ESCRT-III component involved in frontotemporal dementia, causes eye deformities due to Notch misregulation in Drosophila. Cheruiyot A; Lee JA; Gao FB; Ahmad ST FASEB J; 2014 Feb; 28(2):667-75. PubMed ID: 24158394 [TBL] [Abstract][Full Text] [Related]
6. Expression of a human variant of CHMP2B linked to neurodegeneration in Drosophila external sensory organs leads to cell fate transformations associated with increased Notch activity. Wilson C; Kavaler J; Ahmad ST Dev Neurobiol; 2020 Mar; 80(3-4):85-97. PubMed ID: 31587468 [TBL] [Abstract][Full Text] [Related]
7. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Urwin H; Authier A; Nielsen JE; Metcalf D; Powell C; Froud K; Malcolm DS; Holm I; Johannsen P; Brown J; Fisher EM; van der Zee J; Bruyland M; ; Van Broeckhoven C; Collinge J; Brandner S; Futter C; Isaacs AM Hum Mol Genet; 2010 Jun; 19(11):2228-38. PubMed ID: 20223751 [TBL] [Abstract][Full Text] [Related]
8. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology. Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247 [TBL] [Abstract][Full Text] [Related]
9. Rab8, POSH, and TAK1 regulate synaptic growth in a Drosophila model of frontotemporal dementia. West RJ; Lu Y; Marie B; Gao FB; Sweeney ST J Cell Biol; 2015 Mar; 208(7):931-47. PubMed ID: 25800055 [TBL] [Abstract][Full Text] [Related]
10. Genetic screen identifies serpin5 as a regulator of the toll pathway and CHMP2B toxicity associated with frontotemporal dementia. Ahmad ST; Sweeney ST; Lee JA; Sweeney NT; Gao FB Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12168-73. PubMed ID: 19581577 [TBL] [Abstract][Full Text] [Related]
11. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia. Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763 [TBL] [Abstract][Full Text] [Related]
12. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Lee JA; Beigneux A; Ahmad ST; Young SG; Gao FB Curr Biol; 2007 Sep; 17(18):1561-7. PubMed ID: 17683935 [TBL] [Abstract][Full Text] [Related]
13. Ik2/TBK1 and Hook/Dynein, an adaptor complex for early endosome transport, are genetic modifiers of FTD-associated mutant CHMP2B toxicity in Drosophila. Lu Y; West RJH; Pons M; Sweeney ST; Gao FB Sci Rep; 2020 Aug; 10(1):14221. PubMed ID: 32848189 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425 [TBL] [Abstract][Full Text] [Related]
15. Retrovirus reactivation in CHMP2BIntron5 models of frontotemporal dementia. Fort-Aznar L; Ugbode C; Sweeney ST Hum Mol Genet; 2020 Sep; 29(16):2637-2646. PubMed ID: 32628265 [TBL] [Abstract][Full Text] [Related]
16. ESCRT functions in autophagy and associated disease. Rusten TE; Simonsen A Cell Cycle; 2008 May; 7(9):1166-72. PubMed ID: 18418046 [TBL] [Abstract][Full Text] [Related]
17. The functional analysis of the CHMP2B missense mutation associated with neurodegenerative diseases in the endo-lysosomal pathway. Han JH; Ryu HH; Jun MH; Jang DJ; Lee JA Biochem Biophys Res Commun; 2012 May; 421(3):544-9. PubMed ID: 22521643 [TBL] [Abstract][Full Text] [Related]
18. Alteration of the Neuromuscular Junction and Modifications of Muscle Metabolism in Response to Neuron-Restricted Expression of the CHMP2B Waegaert R; Dirrig-Grosch S; Liu H; Boutry M; Luan P; Loeffler JP; René F Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454086 [TBL] [Abstract][Full Text] [Related]
19. CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines. Belly A; Bodon G; Blot B; Bouron A; Sadoul R; Goldberg Y J Cell Sci; 2010 Sep; 123(Pt 17):2943-54. PubMed ID: 20699355 [TBL] [Abstract][Full Text] [Related]
20. Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B. Zhang Y; Schmid B; Nikolaisen NK; Rasmussen MA; Aldana BI; Agger M; Calloe K; Stummann TC; Larsen HM; Nielsen TT; Huang J; Xu F; Liu X; Bolund L; Meyer M; Bak LK; Waagepetersen HS; Luo Y; Nielsen JE; ; Holst B; Clausen C; Hyttel P; Freude KK Stem Cell Reports; 2017 Mar; 8(3):648-658. PubMed ID: 28216144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]